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A new radioimmunoassay which can be used to measure the amounts of tauro-&muricholic acid produced 
by isolated rat hepatocytes in vitro is described. Cross reactivities of other bile acids known to be present 
in rat liver with the antiserum used in the assay were not sufficient to interfere with the measurement of 
tauro-fl-muricholic acid. Exogenous taurochenodeoxycholic acid was metabolised by isolated rat 
hepatocytes concurrently with the appearance of tauro-fl-muricholic acid in the cell. 






Isolated rat hepatocytes have been shown to syn- 
thesise cholic and chenodeoxycholic acids [l-3] 
and are widely used to study bile acid synthesis. 
Glycochenodeoxycholic acid, however, is rapidly 
metabolised by the cells to more polar products [4]. 
Chenodeoxycholic acid is known to be converted 
to (Y- and ,&muricholic acid in rat liver [5,6], and 
it has been recently reported that &muricholic acid 
is synthesised in isolated rat hepatocytes [3]. The 
synthesis of chenodeoxycholic acid in isolated rat 
liver cells, therefore, cannot be studied unless its 
conversion to the muricholic acids is taken into ac- 
count. This paper describes a new radioimmuno- 
assay for tauro-&muricholic acid that can be used 
to measure specifically the amounts of this bile 
acid produced by rat hepatocytes in vitro. 
&muricholic acids were synthesised as in [7] and 
tauro- and glyco-conjugates of the two bile acids 
were prepared as in [8]. The unconjugated and 
conjugated bile acids were purified by repeated 
thin-layer chromatography in solvent systems con- 
sisting of toluene-isopropanol-acetic acid, 
30 : 10 : 1 and ethyl acetate-methanol-acetic acid-- 
water, 35 : 12 : 2: 2, respectively [9,10]. The chro- 
matograms were prepared before application of 
the samples and the bile acids were eluted from the 
silica gel as recommended in [ 111. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Conjugated and unconjugated cy- and fl- 
muricholic acids were identified by their Rf values 
relative to a ,&muricholic acid standard 
(Steraloids, Wilton NH) or to tauro- or glycocholic 
acid [9,10] and by their colour reaction with anis- 
aldehyde [ 121. Solutions of both unconjugated and 
conjugated cy- and ,&muricholic acids were stan- 
dardised with 3cu-hydroxysteroid ehydrogenase 
(Sterognost 3cu Flu, Nyegaard, Oslo) using tauro- 
cholic acid as a standard. 
Collagenase type II was obtained from Sigma 
(London). Bile acids were removed from bovine 
serum albumin fraction V powder as in [2]. cy- and 
2.2. Cell preparation 
Female rats of the Wistar strain (150-250 g) 
were maintained on a pellet diet (Oxoid 86). 
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Hepatocytes were prepared [ 131, and incubated as 
in [2]. Cell viability was 85% as determined by 
trypan blue exclusion. Taurochenodeoxycholic 
acid was added to the incubations in a small 
volume of the incubation buffer. Duplicate cell 
samples were taken at the appropriate times and 
prepared for radioimmunoassay as in [2]. The pro- 
tein content of the cell samples was determined as 
in [14]. 
2.3. Radioimmunoassay 
The conjugated chenodeoxycholic acid content 
of the cells was measured by radioimmunoassay as 
in [15]. 
Antiserum was raised in rabbits to ,&muricholic 
acid-bovine serum albumin immunogen (10 : 1 
molar ratio) as in [ 161. This antiserum was used in 
conjunction with a fl-muricholic acid-histamine 
ligand prepared by the mixed anhydride method 
[16] and purified and characterised as in [15]. The 
@-muricholic acid-histamine ligand was labelled 
with 12’1 as in [15]. The radioimmunoassay of 
tauro-,&muricholic acid was performed as for con- 
jugated cholic acid [ 151, but using a 2-h incuba- 
tion, and a sample volume of 10 ~1 in a final 
volume of 210 ~1. 
3. RESULTS AND DISCUSSION 
The optimal dilution of the antiserum required 
to make the detection limit of the assay most sen- 
sitive [ 151 was found to be 1: 2000. At this titre the 
minimum detection limit, defined as the mass of 
tauro-,&muricholic acid, which gives a response 
within 2.5 x standard deviation (SD) below the 
zero standard, was 0.11 f 0.03 pmol (mean + SD 
from 6 determinations). 
The intra-assay precision of the assay is shown in 
the precision profile derived from 7 consecutive 
assays (fig.1). The coefficient of variation was 
10% over 40-700 nmol/l. The inter-assay preci- 
sion was assessed by repeated analysis of 2 pools of 
tauro-&muricholic acid. At 100 nmol/l and 
400 nmol/l the inter-assay coefficients of variation 
were 14% (9 consecutive assays) and 6% (15 con- 
secutive assays), respectively. 
The relative percentage cross reactivities of the 
antiserum with other bile acids compared to tauro- 
,&muricholic acid are shown in table 1. As in [16], 
lime [mm) 
Fig.1. Precision profile for the radioimmunoassay of 
tauro-,8-muricholic a id derived from 7 consecutive 
assays (mean + SD). 
Table 1 
Relative cross reactivities (Yo) of various bile acids with the antiserum. Tauro-b-muricholic a id being assigned a 
100% cross reactivity 
Tauro-fl-muricholic acid 100 
Glyco-fl-muricholic a id 20 
&Muricholic acid 20 
Tauro-a-muricholic acid 2.0 
Glyco-cu-muricholic acid 1.0 
Lu-Muricholic acid 1.0 
Ursodeoxycholic a id 0.1 
Hyodeoxycholic acid <O.Ol 
Hyocholic acid < 0.01 
Taurocholic acid < 0.001 
Glycocholic acid < 0.001 
Cholic acid <O.ool 
Taurochenodeoxycholic acid 0.006 
Glycochenodeoxycholic acid 0.006 
Chenodeoxycholic a id 0.006 
Taurodeoxycholic a id <O.ool 
Glycodeoxycholic a id <O.ool 
Deoxycholic acid <O.ool 
Taurolithocholic acid 0.04 
Glycolithocholic acid 0.04 
Lithocholic acid 0.01 
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injection of an unconjugated bile acid immunogen 
produced an antiserum specific for the taurine con- 
jugate. Cross reactivities with the majority of bile 
acids likely to be present in rat liver were insignifi- 
cant (< 0.04%). Conjugated and unconjugated a- 
muricholic acids, however, showed cross reac- 
tivities of l-2% and that of ursodeoxycholic acid 
was 0.1%. &Muricholic acid has been reported to 
represent 34.8% of the total bile acids in rat liver, 
while cr-muricholic acid represents 2.6% [17]. The 
concentration of ursodeoxycholic acid found in rat 
liver is also very much lower than that of fi- 
muricholic acid [17,18]. These bile acids, 
therefore, are not present in the liver in sufficient 
quantities to interfere with the measurement of 
tauro-,&muricholic acid by this radioimmuno- 
assay. 
Fig.2 shows the metabolism of taurocheno- 
deoxycholic acid and the synthesis of tauro-fl- 
muricholic acid as measured by the radioimmuno- 
assay in isolated hepatocytes when 10pM tauro- 
chenodeoxycholic acid was added to the incuba- 
tions. The disappearance of taurochenodeoxy- 
cholic acid coincided with the appearance of tauro- 
,&muricholic acid in the cells. After 1 h about 80% 
of the metabolism of taurochenodeoxycholic acid 
was accounted for by tauro-,&muricholic acid. 
These results suggest hat the assay measures a pro- 
duct formed in isolated hepatocytes from tauro- 
chenodeoxycholic acid. The radioimmunoassay is 
sufficiently specific, precise and sensitive to 
measure the amount of tauro-,&-muricholic acid 















Fig.2. Conversion of taurochenodeoxycholic acid to 
tauro-&muricholic acid by isolated hepatocytes. Tauro- 
chenodeoxycholic a id (w); tauro-P-muricholic a id 
(W). 
valuable tool in the study of the synthesis of bile 
acids by rat liver cells in vitro. 
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